The number of Brazilians with a complete vaccine scheme with two doses or with the immunizing agent of a single application against covid-19 reaches 98.831,064 this Saturday, 9. 968,839 applications were registered in the last 24 hours. With vaccination continuing in Brazil, 149.5 million people are partially immunized, that is, they received at least one dose. In relation to the total population, this number is equivalent to 70.07%.
The first doses were applied to 299 thousand people. On the other hand, there were 571,209 with the 2nd application of the vaccine. Single-dose immunizers were given to 1,320 people. The booster doses were administered in 97,221. The data are from the consortium of press vehicles, in partnership with 27 Health secretariats.
The Minister of Health, Marcelo Queiroga, announced at a press conference on Friday, 8th, that Brazil has 354 million doses against covid-19 “acquired or in advanced treatments” to be used in the 2022 immunization campaign. the news, the federal government also stated that it intends to administer only one dose to the public aged 18 to 60 years in the next vaccination cycle. For elderly and immunosuppressed, vaccination will be with two doses.
Read Also
- Kylian Mbappé stays at Paris Saint-Germain and will not go to Real Madrid May 22, 2022
- How is the application that will interrupt your nightmares without waking you up Nov 9, 2020
- The Depp-Heard case explained from start to finish, the jury will meet on Tuesday for its verdict May 28, 2022
- Ray-Ban glasses made by Facebook leaked: this is how they will work Sep 9, 2021
- Notre-Dame-des-Landes: Ten years later, they celebrate the failure of the first dismantling of the ZAD Nov 20, 2022
- The OECD recommends that Spain maintain the ERTE only for the sectors most affected by the pandemic Jul 7, 2021
- Toxic masculinity: “Penetration should not be the end of sex”, says Sainte Paluche Nov 21, 2022
This year, with the exception of people who received the immunizing Janssen, a single dose, the Ministry of Health campaign was planned to apply at least two doses in all age groups covered, including teenagers. For specific audiences, such as the elderly and the immunosuppressed, an additional dose was also administered, which in principle is not planned for next year.